与免疫检查点抑制剂相关心肌炎相关的因素。
Factors Associated With Immune Checkpoint Inhibitor-Related Myocarditis.
作者信息
Zamami Yoshito, Niimura Takahiro, Okada Naoto, Koyama Toshihiro, Fukushima Keijo, Izawa-Ishizawa Yuki, Ishizawa Keisuke
机构信息
Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan.
出版信息
JAMA Oncol. 2019 Nov 1;5(11):1635-1637. doi: 10.1001/jamaoncol.2019.3113.
Abstract
This analysis investigates risk factors for immune checkpoint inhibitor–related myocarditis using a large pool of data gathered from the US Food and Drug Administration Adverse Event Reporting System database.
摘要
本分析使用从美国食品药品监督管理局不良事件报告系统数据库收集的大量数据，研究免疫检查点抑制剂相关心肌炎的风险因素。
相似文献
1
Factors Associated With Immune Checkpoint Inhibitor-Related Myocarditis.与免疫检查点抑制剂相关心肌炎相关的因素。
JAMA Oncol. 2019 Nov 1;5(11):1635-1637. doi: 10.1001/jamaoncol.2019.3113.
2
Immune checkpoint inhibitor-related myocarditis.免疫检查点抑制剂相关心肌炎
Jpn J Clin Oncol. 2018 Jan 1;48(1):7-12. doi: 10.1093/jjco/hyx154.
3
Asymptomatic Immune Checkpoint Inhibitor-associated Myocarditis.无症状免疫检查点抑制剂相关心肌炎。
Intern Med. 2021 Feb 15;60(4):569-573. doi: 10.2169/internalmedicine.5412-20. Epub 2020 Oct 7.
4
Diagnosis of immune checkpoint inhibitor-associated myocarditis: A systematic review.免疫检查点抑制剂相关性心肌炎的诊断：系统评价。
Int J Cardiol. 2019 Dec 1;296:113-121. doi: 10.1016/j.ijcard.2019.07.025. Epub 2019 Jul 11.
5
Immune checkpoint inhibitor myocarditis.免疫检查点抑制剂性心肌炎。
Curr Opin Cardiol. 2019 May;34(3):303-306. doi: 10.1097/HCO.0000000000000622.
6
A retrospective study of immune checkpoint inhibitor-associated myocarditis in a single center in China.中国单中心免疫检查点抑制剂相关性心肌炎的回顾性研究。
Chin Clin Oncol. 2020 Apr;9(2):16. doi: 10.21037/cco.2020.03.08. Epub 2020 Apr 7.
7
Immune checkpoint inhibitor therapy and myocarditis: a systematic review of reported cases.免疫检查点抑制剂治疗与心肌炎：已报告病例的系统综述。
J Cancer Res Clin Oncol. 2019 Jun;145(6):1527-1557. doi: 10.1007/s00432-019-02927-x. Epub 2019 Apr 26.
8
Immune Checkpoint Inhibitor-Associated Myocarditis.免疫检查点抑制剂相关性心肌炎。
Oncologist. 2018 Aug;23(8):879-886. doi: 10.1634/theoncologist.2018-0130. Epub 2018 May 25.
9
Plasma Exchange for Immune Checkpoint Inhibitor-Induced Myocarditis.用于免疫检查点抑制剂诱导的心肌炎的血浆置换
CJC Open. 2020 Nov 14;3(3):379-382. doi: 10.1016/j.cjco.2020.11.004. eCollection 2021 Mar.
10
Pre-Existing Cardiovascular Conditions as Clinical Predictors of Myocarditis Reporting with Immune Checkpoint Inhibitors: A VigiBase Study.既往心血管疾病作为免疫检查点抑制剂相关心肌炎报告的临床预测因素：一项VigiBase研究
Cancers (Basel). 2020 Nov 23;12(11):3480. doi: 10.3390/cancers12113480.
引用本文的文献
1
Atrial Fibrillation and Cancer: Pathophysiological Mechanism and Clinical Implications.心房颤动与癌症：病理生理机制及临床意义
J Clin Med. 2025 Aug 7;14(15):5600. doi: 10.3390/jcm14155600.
2
Risk factors of immune checkpoint inhibitor-related cardiotoxicity: a scoping review.免疫检查点抑制剂相关心脏毒性的危险因素：一项范围综述
Oncologist. 2025 Jul 4;30(7). doi: 10.1093/oncolo/oyaf187.
3
Pharmacovigilance study for the identification of mogamulizumab-induced immune-related adverse events using a real-world database.利用真实世界数据库进行的用于识别莫加莫拉单抗诱导的免疫相关不良事件的药物警戒研究。
Oncologist. 2025 Jul 4;30(7). doi: 10.1093/oncolo/oyaf201.
4
Effect of immune checkpoint inhibitor therapy on biventricular mechanics in cancer patients over a short-term follow-up: a systematic review.免疫检查点抑制剂疗法对癌症患者短期随访期间双心室力学的影响：一项系统综述
Front Immunol. 2025 Jun 6;16:1576175. doi: 10.3389/fimmu.2025.1576175. eCollection 2025.
5
A review of immune checkpoint inhibitor-associated myocarditis: Epidemiology, pathogenesis, and biomarkers.免疫检查点抑制剂相关性心肌炎综述：流行病学、发病机制及生物标志物
Hum Vaccin Immunother. 2025 Dec;21(1):2512645. doi: 10.1080/21645515.2025.2512645. Epub 2025 Jun 12.
6
Unmasking the Rare but Lethal Cardiac Complications of Immune Checkpoint Inhibitor Therapy: A Review of Mechanisms, Risk Factors, and Management Strategies.揭示免疫检查点抑制剂治疗罕见但致命的心脏并发症：机制、危险因素及管理策略综述
Curr Treat Options Oncol. 2025 May 24. doi: 10.1007/s11864-025-01329-1.
7
Preclinical mouse models of immune checkpoint inhibitor-associated myocarditis.免疫检查点抑制剂相关心肌炎的临床前小鼠模型
Nat Cardiovasc Res. 2025 May;4(5):526-538. doi: 10.1038/s44161-025-00640-2. Epub 2025 May 7.
8
Time dependent predictors of cardiac inflammatory adverse events in cancer patients receiving immune checkpoint inhibitors.接受免疫检查点抑制剂治疗的癌症患者心脏炎症不良事件的时间依赖性预测因素。
Cardiooncology. 2025 Apr 28;11(1):40. doi: 10.1186/s40959-025-00331-8.
9
Multimodal Imaging of Immune Checkpoint Inhibitor Myocarditis.免疫检查点抑制剂相关性心肌炎的多模态成像
J Clin Med. 2025 Apr 21;14(8):2850. doi: 10.3390/jcm14082850.
10
Sex-Related Differences in Immunotherapy Toxicities: Insights into Dimorphic Responses.免疫治疗毒性中的性别差异：对两性反应的见解。
Cancers (Basel). 2025 Mar 21;17(7):1054. doi: 10.3390/cancers17071054.
Zotero 插件